Trump, Medicare and Generic drug

Trump administration defends Medicare drug price talks in case brought by Novartis
The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate prescription drug prices, a sign that some consumer advocates said suggests the Trump administration is willing to maintain the controversial program.
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Mintz IRA Update — From the Desk of ML Strategies: The Medicare Drug Price Negotiation Program Under the Second Trump Administration
The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future of the IRA’s
Trump to Meet Pharma Leaders as They Seek Drug Policy Changes
The industry is also pushing for curbs on the rebates they pay pharmacy benefit managers, which act as middlemen between drug companies and consumers, in exchange for favorable pl
Trump to Meet Pharma CEOs to Discuss Drug Pricing, Tariffs, and Medicare Negotiations
U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy benefit managers (PBMs),
Sandoz to pay $275 million to settle drug price-fixing case
Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
How Medicare Says It Arrives At ‘Fair’ Prescription Drug Prices
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
PhRMA CEO: 'Key reforms still need to be enacted' for the price of drugs
PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...
WVXU18h
Senate approves 'aggressive' reforms for pharmacy benefit managers to lower drug prices
Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...
The Associated Press on MSN12d
Drug lord's son-in-law pleads guilty in border price-fixing scheme
The son-in-law of a Mexican drug lord entered a guilty plea over an 11-year price-fixing scheme that used deadly force along ...
Mankato Free Press2d
Drug prices, health care staffing topics at senior care roundtable with Klobuchar staff
As DFL Sen. Amy Klobuchar’s staff facilitated a conversation around staffing at health care and assisted living facilities ...
What a $2 million per dose gene therapy reveals about drug pricing
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
When online weight-loss drugs are too good to be true
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...